作者: Masahiro Natsuaki , Yutaka Furukawa , Takeshi Morimoto , Yoshihisa Nakagawa , Masaharu Akao
关键词:
摘要: Background: Among hemodialysis (HD) patients, those who have diabetes poorer cardiovascular outcomes than non-diabetic but the impact of on has not been fully elucidated in HD patients undergoing coronary revascularization. Methods and Results: We identified 375 (203 diabetes, 172 non-diabetes) 9,006 without (3,455 5,551 database CREDO-Kyoto registry their first In non-HD significantly higher risks death (10.8% vs. 7.7%, P<0.0001; adjusted hazard ratio (HR) 1.29, P<0.0001) major adverse events (MACE), a composite death, myocardial infarction stroke (18.8% 13.3%, HR 1.36, were seen diabetic through 4-year follow-up. Analysis showed that duration before revascularization was shorter (median interval: 858 2,216 days, P<0.0001). contrast to results (41.9% 39.1%, P=0.75; 0.98, P=0.93) MACE (45.6% 45.8%, P=0.83; 0.87, P=0.50) after comparable between patients. There significant interactions for MACE. Conclusions: require extremely poor irrespective concomitant diabetes. (Circ J 2011; 75: 1616-1625)